2017
DOI: 10.1002/acr.22820
|View full text |Cite
|
Sign up to set email alerts
|

A 66‐Year‐Old Woman With Hemoptysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 46 publications
(51 reference statements)
0
2
0
Order By: Relevance
“…With the advent of B-cell depletion therapy for ANCA associated vasculitis, several authors have reported successful treatment of vasculitic leg ulcers with rituximab (Rituxan®, Genentech) (31, 32). …”
Section: Leg Ulcers Due To Anca-associated Vasculitismentioning
confidence: 99%
“…With the advent of B-cell depletion therapy for ANCA associated vasculitis, several authors have reported successful treatment of vasculitic leg ulcers with rituximab (Rituxan®, Genentech) (31, 32). …”
Section: Leg Ulcers Due To Anca-associated Vasculitismentioning
confidence: 99%
“…As with ulcers caused by other autoimmune etiologies, aggressive treatment of the underlying autoimmune disease often results in healing of the wound (27, 29). With the advent of B-cell depletion therapy for ANCA associated vasculitis, several authors have reported successful treatment of vasculitic leg ulcers with rituximab (Rituxan®, Genentech) (29, 30). …”
Section: Overview Of Vasculitic Woundsmentioning
confidence: 99%